Pansclerotic morphea is characterized by IFN-γ responses priming dendritic cell fibroblast crosstalk to promote fibrosis.
Pansclerotic morphea is characterized by IFN-γ responses priming dendritic cell fibroblast crosstalk to promote fibrosis.
复制标题
DOI:
10.1172/jci.insight.171307
复制
发表时间:
2023-08-22
期刊:
影响因子:
8
通讯作者:
Khanna, Dinesh
中科院分区:
文献类型:
--
作者:
Xing, Enze;Ma, Feiyang;Wasikowski, Rachael;Billi, Allison C.;Gharaee-Kermani, Mehrnaz;Fox, Jennifer;Dobry, Craig;Victory, Amanda;Sarkar, Mrinal K.;Xing, Xianying;Plazyo, Olesya;Chen, Henry W.;Barber, Grant;Jacobe, Heidi;Tsou, Pei-Suen;Modlin, Robert L.;Varga, John;Kahlenberg, J. Michelle;Tsoi, Lam C.;Gudjonsson, Johann E.;Khanna, Dinesh
Pansclerotic morphea (PSM) is a rare, devastating disease characterized by extensive soft tissue fibrosis, secondary contractions, and significant morbidity. PSM pathogenesis is unknown, and aggressive immunosuppressive treatments rarely slow disease progression. We aimed to characterize molecular mechanisms driving PSM and to identify therapeutically targetable pathways by performing single-cell and spatial RNA-Seq on 7 healthy controls and on lesional and nonlesional skin biopsies of a patient with PSM 12 months apart. We then validated our findings using immunostaining and in vitro approaches. Fibrotic skin was characterized by prominent type II IFN response, accompanied by infiltrating myeloid cells, B cells, and T cells, which were the main IFN-γ source. We identified unique CXCL9+ fibroblasts enriched in PSM, characterized by increased chemokine expression, including CXCL9, CXCL10, and CCL2. CXCL9+ fibroblasts were related to profibrotic COL8A1+ myofibroblasts, which had enriched TGF-β response. In vitro, TGF-β and IFN-γ synergistically increased CXCL9 and CXCL10 expression, contributing to the perpetuation of IFN-γ responses. Furthermore, cell-to-cell interaction analyses revealed cDC2B DCs as a key communication hub between CXCL9+ fibroblasts and COL8A1+ myofibroblasts. These results define PSM as an inflammation-driven condition centered on type II IFN responses. This work identified key pathogenic circuits between T cells, cDC2Bs, and myofibroblasts, and it suggests that JAK1/2 inhibition is a potential therapeutic option in PSM.
登录
查看更多内容
DOI:
10.3899/jrheum.130029
发表时间:
2014-01
期刊:
The Journal of rheumatology
影响因子:
--
作者:
Kim A;Marinkovich N;Vasquez R;Jacobe HT
通讯作者:
Jacobe HT
DOI:
10.1084/jem.170.3.727
发表时间:
1989-09-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Khalil N;Bereznay O;Sporn M;Greenberg AH
通讯作者:
Greenberg AH
影响因子:
2.6
作者:
Mirizio E;Liu C;Yan Q;Waltermire J;Mandel R;Schollaert KL;Konnikova L;Wang X;Chen W;Torok KS
通讯作者:
Torok KS
影响因子:
4.8
作者:
Midgley, Adam C.;Rogers, Mathew;Steadman, Robert
通讯作者:
Steadman, Robert
影响因子:
13.8
作者:
Fett, Nicole;Werth, Victoria P.
通讯作者:
Werth, Victoria P.